Independent clinical research in Europe
- 1 November 2004
- journal article
- viewpoint
- Published by Elsevier in The Lancet
- Vol. 364 (9446) , 1723-1726
- https://doi.org/10.1016/s0140-6736(04)17360-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002BMJ, 2003
- European Organisation for Research and Treatment of Cancer's point of viewThe Lancet, 2003
- EU directive on clinical trials penalizes small sponsorsNature Biotechnology, 2003
- Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsBMJ, 2003
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003
- Facing our demonsNature Reviews Drug Discovery, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- The pharmaceutical industry as a medicines providerThe Lancet, 2002
- Drugs for neglected diseases: a failure of the market and a public health failure?Tropical Medicine & International Health, 2001
- Relation between agendas of the research community and the research consumerThe Lancet, 2000